Literature DB >> 8088292

Treatment of fever in childhood.

D Adam1, G Stankov.   

Abstract

Although the need for routine antipyretic therapy in children has often been questioned, there are no data to contra-indicate this. Not all fevers need to be treated but many physicians do so to relieve parental concern. The most commonly used antipyretic drugs are acetylsalicylic acid (ASA), paracetamol (acetaminophen) and dipyrone (metamizol). Paracetamol and ASA have been extensively evaluated but there are few clinical trials on dipyrone. In the last decade a strong statistical association has been observed between salicylates and Reye syndrome. Paracetamol is the most common cause of acute hepatic failure. Dipyrone has been associated with agranulocytosis. In the light of these findings the extensive use of antipyretics drugs has been seriously questioned.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8088292     DOI: 10.1007/bf01983400

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  92 in total

1.  AGRANULOCYTOSIS INDUCED BY DIPYRONE, A HAZARDOUS ANTIPYRETIC AND ANALGESIC.

Authors:  C M HUGULEY
Journal:  JAMA       Date:  1964-09-21       Impact factor: 56.272

2.  Antipyretic activity of acetylsalicylic acid and salicylamide suspension in pediatrics. A comparative clinical evaluation in two hundred six cases.

Authors:  M P BOROVSKY
Journal:  Am J Dis Child       Date:  1960-07

3.  Changes in the pattern of neonatal septicemia and meningitis.

Authors:  G H McCracken; H R Shinefield
Journal:  Am J Dis Child       Date:  1966-07

4.  Paracetamol overdose and liver damage.

Authors:  P G Rose
Journal:  Br Med J       Date:  1969-02-08

5.  Potential bacteremia in pediatric practice.

Authors:  R Hoekelman; E B Lewin; M B Shapira; S A Sutherland
Journal:  Am J Dis Child       Date:  1979-10

Review 6.  Gram-negative bacteremia. IV. Re-evaluation of clinical features and treatment in 612 patients.

Authors:  B E Kreger; D E Craven; W R McCabe
Journal:  Am J Med       Date:  1980-03       Impact factor: 4.965

7.  Spontaneous fits after convulsions with fever.

Authors:  S J Wallace
Journal:  Arch Dis Child       Date:  1977-03       Impact factor: 3.791

8.  Efficacy of sponging vs acetaminophen for reduction of fever. Sponging Study Group.

Authors:  A D Friedman; L L Barton
Journal:  Pediatr Emerg Care       Date:  1990-03       Impact factor: 1.454

Review 9.  Treatment of fever in 1982: a review.

Authors:  A K Done
Journal:  Am J Med       Date:  1983-06-14       Impact factor: 4.965

10.  Pyrexia in infection in the elderly.

Authors:  C H McAlpine; B J Martin; I M Lennox; M A Roberts
Journal:  Age Ageing       Date:  1986-07       Impact factor: 10.668

View more
  6 in total

1.  Fever--concepts old and new.

Authors:  I Blumenthal
Journal:  J R Soc Med       Date:  1997-07       Impact factor: 5.344

2.  Analgesic efficacy and safety of paracetamol-codeine combinations versus paracetamol alone: a systematic review.

Authors:  A J de Craen; G Di Giulio; J E Lampe-Schoenmaeckers; A G Kessels; J Kleijnen
Journal:  BMJ       Date:  1996-08-10

3.  Prehospital use of paracetamol among children attending the accident and emergency department.

Authors:  S Mason; S Thorp; D Burke
Journal:  Emerg Med J       Date:  2003-01       Impact factor: 2.740

Review 4.  Paracetamol for treating fever in children.

Authors:  M Meremikwu; A Oyo-Ita
Journal:  Cochrane Database Syst Rev       Date:  2002

5.  Intramuscular Dipyrone versus Oral Ibuprofen or Nimesulide for Reduction of Fever in the Outpatient Setting.

Authors:  Hayri L Yilmaz; Nazan Alparslan; Dincer Yildizdas; Ibrahim Bayram; Emre Alhan
Journal:  Clin Drug Investig       Date:  2003       Impact factor: 2.859

6.  Beliefs and practices regarding childhood fever among parents: a cross-sectional study from Palestine.

Authors:  Sa'ed H Zyoud; Samah W Al-Jabi; Waleed M Sweileh; Masa M Nabulsi; Mais F Tubaila; Rahmat Awang; Ansam F Sawalha
Journal:  BMC Pediatr       Date:  2013-04-28       Impact factor: 2.125

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.